PRME
Prime Medicine, Inc.
3.50$
+9.0%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | -400.8% | – | – | – | – | – | – | |
| – | +0.9% | +5.5% | +17.0% | +1.3% | +10.2% | -10.5% | -5.4% | +29.5% | -72.7% | +261.1% | -3.8% | – | |
| – | +5.0% | +17.6% | +55.3% | -15.6% | -13.0% | -4.4% | +11.3% | +101.5% | -64.6% | +2.9% | +4.8% | – | |
| – | +502.3% | -308.4% | – | -59.1% | +1,266.3% | -115.7% | – | +11.1% | +89.8% | -316.3% | – | – | |
| – | -36.7% | +26.3% | -18.2% | -32.9% | +40.3% | +35.2% | -35.1% | -84.3% | +17.4% | -26.2% | -78.5% | – | |
| – | – | -189.7% | – | +630.2% | -4.1% | -198.9% | – | -3,424.5% | – | +53.2% | -44.6% | – | |
| – | -39.0% | +80,996.4% | -100.0% | +109,937.1% | -100.0% | +599,900.0% | -96.7% | +73,378.7% | -99.6% | -30.1% | -8.1% | – | |
| – | – | – | -173.3% | – | +2.5% | -240.5% | – | – | -147.5% | – | -1,650.7% | – | |
| – | – | – | – | – | – | -454.8% | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.